SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Hossein Borghaei
◽
Mary W. Redman
◽
Karen Kelly
◽
Saima N. Waqar
◽
Francisco Robert
◽
...